全文获取类型
收费全文 | 104756篇 |
免费 | 11204篇 |
国内免费 | 3249篇 |
专业分类
耳鼻咽喉 | 749篇 |
儿科学 | 1607篇 |
妇产科学 | 1210篇 |
基础医学 | 19956篇 |
口腔科学 | 2783篇 |
临床医学 | 6559篇 |
内科学 | 15435篇 |
皮肤病学 | 1908篇 |
神经病学 | 11413篇 |
特种医学 | 2844篇 |
外国民族医学 | 27篇 |
外科学 | 8366篇 |
综合类 | 10370篇 |
现状与发展 | 14篇 |
预防医学 | 4135篇 |
眼科学 | 1066篇 |
药学 | 16938篇 |
34篇 | |
中国医学 | 4010篇 |
肿瘤学 | 9785篇 |
出版年
2024年 | 190篇 |
2023年 | 1775篇 |
2022年 | 2563篇 |
2021年 | 4914篇 |
2020年 | 4142篇 |
2019年 | 4416篇 |
2018年 | 4220篇 |
2017年 | 4187篇 |
2016年 | 3916篇 |
2015年 | 4438篇 |
2014年 | 6435篇 |
2013年 | 6676篇 |
2012年 | 5908篇 |
2011年 | 7037篇 |
2010年 | 5649篇 |
2009年 | 5674篇 |
2008年 | 5591篇 |
2007年 | 4761篇 |
2006年 | 4084篇 |
2005年 | 3771篇 |
2004年 | 3186篇 |
2003年 | 2831篇 |
2002年 | 2120篇 |
2001年 | 1795篇 |
2000年 | 1493篇 |
1999年 | 1408篇 |
1998年 | 1355篇 |
1997年 | 1316篇 |
1996年 | 1211篇 |
1995年 | 1107篇 |
1994年 | 1019篇 |
1993年 | 967篇 |
1992年 | 761篇 |
1991年 | 682篇 |
1990年 | 586篇 |
1989年 | 497篇 |
1988年 | 474篇 |
1987年 | 473篇 |
1986年 | 572篇 |
1985年 | 779篇 |
1984年 | 741篇 |
1983年 | 581篇 |
1982年 | 579篇 |
1981年 | 488篇 |
1980年 | 449篇 |
1979年 | 374篇 |
1978年 | 229篇 |
1977年 | 190篇 |
1976年 | 197篇 |
1975年 | 121篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Tianjiao Lyu Yahui Jiang Nan Jia Xiaoxia Che Qin Li Yinhua Yu Keqin Hua Robert C. Bast Jr Weiwei Feng 《International journal of cancer. Journal international du cancer》2020,146(6):1553-1567
Detachment of cancer cells from the primary tumor and formation of spheroids in ascites is required for implantation metastasis in epithelial ovarian cancer (EOC), but the underlying mechanism of this process has not been thoroughly elucidated. To mimic this process, ovarian cancer cells were grown in 3D and 2D culture. Hey and OVCA433 spheroids exhibited decreased cell proliferation and enhanced adhesion and invasion. SMYD3 expression was elevated in ovarian carcinoma spheroids in association with increased H3K4 methylation. Depletion of SMYD3 by transient siRNA, stable shRNA knockdown and the SMYD3 inhibitor BCI-121 all decreased spheroid invasion and adhesion. Gene expression arrays revealed downregulation of integrin family members. Inhibition assays confirmed that invasion and adhesion of spheroids are mediated by ITGB6 and ITGAM. SMYD3-deficient cells regained the ability to invade and adhere after forced overexpression of SMYD3, ITGB6 and ITGAM. However, this biological ability was not restored by forced overexpression of SMYD3 in ITGB6- and/or ITGAM-deficient cancer cells. SMYD3 and H3K4me3 binding at the ITGB6 and ITGAM promoters was increased in spheroids compared to that in monolayer cells, and the binding was decreased when SMYD3 expression was inhibited, consistent with the expression changes in integrins. SMYD3 expression and integrin-mediated adhesion were also activated in an intraperitoneal xenograft model and in EOC patient spheroids. In vivo, SMYD3 knockdown inhibited tumor metastasis and reduced ascites volume in both the intraperitoneal xenograft model and a PDX model. Overall, our results suggest that the SMYD3-H3K4me3-integrin pathway plays a crucial role in ovarian cancer metastasis to the peritoneal surface. 相似文献
62.
目的:探讨蓝莓花青素(BA)对人胃腺癌BGC-823细胞增殖、侵袭的影响及相关机制。方法:低、中、高剂量实验组与对照组人胃腺癌BGC-823细胞分别以25、50、100μg/mL BA与等量生理盐水处理,分别处理12 h、24 h、48 h。采用噻唑蓝(MTT)与流式细胞仪检测人胃腺癌BGC-823细胞增殖与凋亡;采用Transwell小室实验与免疫细胞化学法检测人胃腺癌BGC-823细胞侵袭与P53、半胱氨酸蛋白酶-3(Caspase-3)蛋白表达。结果:干预48 h时,对照组、低、中、高剂量实验组人胃腺癌BGC-823细胞P53与Caspase-3蛋白阳性细胞百分比分别为(11.12±1.01)%,(24.31±2.18)%,(47.56±2.91)%,(66.49±5.14)%与(15.04±1.23)%,(28.22±3.09)%,(69.36±5.42)%,(86.52±6.15)%。实验组胃腺癌BGC-823细胞增殖抑制率随BA浓度增大而逐渐升高;与对照组比较,低、中、高剂量实验组人胃腺癌BGC-823细胞凋亡率、P53与Caspase-3蛋白阳性细胞百分比均显著升高,侵袭率降低,呈浓度依赖性(均P0.05)。结论:BA可有效抑制胃腺癌BGC-823细胞增殖,诱导其凋亡,并降低侵袭能力,其机制可能与上调P53与Caspase-3蛋白表达有关。 相似文献
63.
64.
65.
66.
67.
68.
69.
Fei Xu Ming‐Liang Ye Yu‐Peng Zhang Wen‐Jie Li Meng‐Ting Li Hai‐Zhou Wang Xiao Qiu Yan Xu Jin‐Wen Yin Qian Hu Wan‐Hui Wei Ying Chang Lan Liu Qiu Zhao 《Cancer science》2020,111(5):1528-1541
Resistance to chemotherapy is a major challenge for the treatment of patients with colorectal cancer (CRC). Previous studies have found that microRNAs (miRNAs) play key roles in drug resistance; however, the role of miRNA‐373‐3p (miR‐375‐3p) in CRC remains unclear. The current study aimed to explore the potential function of miR‐375‐3p in 5‐fluorouracil (5‐FU) resistance. MicroRNA‐375‐3p was found to be widely downregulated in human CRC cell lines and tissues and to promote the sensitivity of CRC cells to 5‐FU by inducing colon cancer cell apoptosis and cycle arrest and by inhibiting cell growth, migration, and invasion in vitro. Thymidylate synthase (TYMS) was found to be a direct target of miR‐375‐3p, and TYMS knockdown exerted similar effects as miR‐375‐3p overexpression on the CRC cellular response to 5‐FU. Lipid‐coated calcium carbonate nanoparticles (NPs) were designed to cotransport 5‐FU and miR‐375‐3p into cells efficiently and rapidly and to release the drugs in a weakly acidic tumor microenvironment. The therapeutic effect of combined miR‐375 + 5‐FU/NPs was significantly higher than that of the individual treatments in mouse s.c. xenografts derived from HCT116 cells. Our results suggest that restoring miR‐375‐3p levels could be a future novel therapeutic strategy to enhance chemosensitivity to 5‐FU. 相似文献
70.
《药学学报(英文版)》2020,10(7):1294-1308
A great challenge in multi-targeting drug discovery is to identify drug-like lead compounds with therapeutic advantages over single target inhibitors and drug combinations. Inspired by our previous efforts in designing antitumor evodiamine derivatives, herein selective histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) dual inhibitors were successfully identified, which showed potent in vitro and in vivo antitumor potency. Particularly, compound 30a was orally active and possessed excellent in vivo antitumor activity in the HCT116 xenograft model (TGI = 75.2%, 150 mg/kg, p.o.) without significant toxicity, which was more potent than HDAC inhibitor vorinostat, TOP inhibitor evodiamine and their combination. Taken together, this study highlights the therapeutic advantages of evodiamine-based HDAC1/TOP2 dual inhibitors and provides valuable leads for the development of novel multi-targeting antitumor agents. 相似文献